Publications – Grants

D-Lab

DuCAT, Dutch Network of Computer Assisted Theragnostics
Grant # 10696
Period: 2014-2019
Project coordinator: Prof. Dr. Philippe Lambin
Sum awarded: 1.289k€
Funded by: STW

Non-invasive STRatification of Tissue heterogeneity of personalized medicine – (Radiomics STRaTegy)
Grant: P14-19, 2.1: 14931
Period: 2016-2021
Program leader: Philippe Lambin; Project coordinator 2.1: Philippe Lambin
Sum awarded: k€1.476 for the program
Funded by: STW

A new era in personalised medicine: Radiomics as decision support tool for diagnostics and theragnostics in oncology (PREDICT)
Grant: 766276
Period: 2017-2021
Project coordinator: Philippe Lambin
Sum awarded: €1.044.267 (UM)
Funded by: EU. Marie Curie ITN

Imaging-based Big Data for decision support systems for cancer: productization and sustainable
research and development of Radiomics products (EURADIOMICS)
Grant: 30943400N
Period: 2017 – 2019
Project coordinator: Philippe Lambin
Sum awarded: €176.782
Funded by: Interreg

A novel multifactorial biomarker-based Companion Predictive Model for
hypoxia-activated prodrugs (COMPACT)
Grant: 18106
Period: 2018 – 2021
Project coordinator: Philippe Lambin
Sum awarded: €182.750
Funded by: EuroSTARS

Validation of multiparametric models and Circulating and imaging biomarkers to improve Lung cancer EARLY detection (CLEARLY)
Grant: UM2017-8295
Period: 2018 – 2021
Project coordinator: Philippe Lambin
Sum awarded: €300.000
Funded by: TRANSCAN, KWF (national)

Quantitative Neuro-Imaging with Radiomics and Deep Learning in two main neurological diseases: Multiple Sclerosis and Stroke (QUANTIM)
Grant: –
Period: 2018 – 2022
Project coordinator: Philippe Lambin, Eric Salmon
Sum awarded: PhD student
Funded by: Imaging Valley (UM-ULiege)

Quantitative Imaging in nuclear medicine with Deep Learning: applications to bone and liver (DEEP-NUCLE)
Grant: –
Period: 2018 – 2022
Project coordinator: Felix Mottaghy, Philippe Lambin, Roland Hustinx
Sum awarded: PhD student
Funded by: Imaging Valley (UM-ULiege)

Preventing unnecessary surgery by distinguishing benign from malignant renal cystic lesions in CT images: A quantitative imaging approach
Grant: 12085
Period: 2019 – 2020
Project coordinator: Henry Woodruff
Sum awarded: k€150
Funded by: KWF kankerbestrijding

Short term changes in “Radiomic” features predict long-term treatment effectiveness
Grant: 19-1040MS
Period: 2019 – 2020
Project coordinator: Phlippe Lambin
Sum awarded: k€60
Funded by: Stichting MS Research

The application of deep learning in contrast enhanced mammography: towards a virtual breast biopsy DEEP-MAM
Grant: 12931
Period: 2019 – 2022
Project coordinator: Philippe Lambin
Sum awarded: k€125
Funded by: EU Eurostars

M-Lab

Exploiting intratumour heterogenety with heterogeneous irradiation
Grant # –
Period: 2013-2017
Project coordinator: Prof. Dr. Philippe Lambin
Sum awarded: 320k€
Funded by: KOFL (kankeronderzoek fonds Limburg)

Radiation Innovations for Therapy and Education (RADIATE)
Grant # 642623
Period: 2014-2018
Project coordinator: International network, Maastricht Prof. Dr. Philippe Lambin
Sum awarded: 510k€
Funded by: EU H2020

Mitochondrial genetics for the prediction of radiotherapy-induced lung toxicity risk: a prospective multicentre and mechanistic study
Grant: UM2015-7635
Period: 2015-2019
Project coordinator: Cary Oberije
Sum awarded: k€572
Funded by: KWF kankerbestrijding

Form men to mice and back again – completing a 60 year innovation cycle with “armed”clostridia as safe and specific weapons to fight cancer
Grant: UM2015-8025
Period: 2016-2022
Project coordinator: Jan Theys, Ludwig Dubois, Philippe Lambin
Sum awarded: k€2.085
Funded by: KWF kankerbestrijding

Tackling the Achilles Heel of Immunotherapy: Validating imaging biomarkers and targeting the immunological niche of tumour hypoxia (HYPOXIMMUNO)
Grant: 694812
Period: 2016-2021
Project coordinator: Philippe Lambin
Sum awarded: k€2.499
Funded by: EU, ERC advanced

Clinical proof of concept through a randomised phase II study: a combination of immunotherapy and stereotactic ablative radiotherapy as a curative treatment for limited metastatic lung cancer (IMMUNOSABR)
Grant: 733008
Period: 2017- 2022
Project coordinator: Philippe Lambin
Sum awarded: k€5,994
Funded by: H2020, EU

Trojan horses against cancer: the use of harmless clostridia bacteria to continuously produce immunomodulatory anti-cancer agents specifically within the tumor (TROJAN HORSES)
Grant: 11163
Period: 2018 – 2020
Project coordinator: Philippe Lambin
Sum awarded: €152.042 (at AzM)
Funded by: KWF

Commercial feasibility of non-pathogenic Clostridium-Mediated Cancer Immunotherapy: leveraging the presence of tumour hypoxia & necrosis (CL-IO)
Grant: 813200
Period: 2018 – 2020
Project coordinator: Philippe Lambin
Sum awarded: k€150
Funded by: EU, ERC – PoC

Is charged particle radiation more immunogenic than standard photon therapy? A preclinical study’
Grant: 11965
Period: 2020-2021
Project coordinator: Ala Yaromina
Sum awarded: k€150
Funded by: KWF kankerbestrijding

BUY NOW